股票/基金 实时行情 股吧

简称：鲁抗医药 代码：600789


会计年度:2021-12-31收入分布
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计4,890,672,608.423,744,179,456.501,146,493,151.9223.44
其他212,599,365.18175,466,424.1737,132,941.0117.47
其他(补充)88,049,489.8765,620,752.6822,428,737.1925.47
人用抗生素2,976,349,123.952,283,492,204.10692,856,919.8523.28
兽用抗生素1,613,674,629.421,219,600,075.55394,074,553.8724.42

会计年度:2020-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计4,205,109,097.873,224,976,978.96980,132,118.9123.31
其他164,298,023.00139,618,147.6524,679,875.3515.02
其他(补充)61,876,136.5944,336,691.8317,539,444.7628.35
人用抗生素2,624,970,919.931,999,806,601.09625,164,318.8423.82
兽用抗生素1,353,964,018.351,041,215,538.39312,748,479.9623.10

会计年度:2019-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计3,732,718,882.942,677,035,967.701,055,682,915.2428.28
其他74,509,336.9844,880,163.6129,629,173.3739.77
其他(补充)46,066,850.2839,910,083.246,156,767.0413.36
人用抗生素2,701,731,379.091,920,392,334.50781,339,044.5928.92
兽用抗生素910,411,316.59671,853,386.35238,557,930.2426.20

会计年度:2018-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计3,329,604,787.412,292,496,861.401,037,107,926.0131.15
其他71,229,906.1758,918,106.7512,311,799.4217.28
其他(补充)49,976,845.1746,493,206.133,483,639.046.97
人用抗生素2,070,380,264.451,435,036,554.45635,343,710.0030.69
兽用抗生素1,138,017,771.62752,048,994.07385,968,777.5533.92

会计年度:2017-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计2,568,706,618.621,861,536,551.42707,170,067.2027.53
其他115,176,320.80105,263,394.069,912,926.748.61
人用抗生素1,765,925,260.641,248,375,909.77517,549,350.8729.31
兽用抗生素687,605,037.18507,897,247.59179,707,789.5926.14

    1/8 转到 
和讯恭候您的意见 - 联系我们 - 关于我们 - 广告服务
违法和不良信息举报电话：010-85650899 传真：010-85650844 邮箱：yhts@staff.hexun.com
Copyright©和讯网 北京和讯在线信息咨询服务有限公司 All Rights Reserved 版权所有 复制必究 京ICP备10021077号